Table 1: aSeroepidemiological data of coinfection of malaria with lymphatic filariasis (LF) and human immunodeficiency virus (HIV).

Vulnerable cross-border LFcHIVd
Myanmar populationbPositiveNegativeTotalPositiveNegativeTotal

Health worker
 TBF-positivee1222302323
 TBF-negative1424304343
Total 646606666

Non-health worker
 TBF-positivee077167
 TBF-negative2121421214
Total 1921 1821

Data modified from our previously published findings of serological diagnosis of plasma samples of  b87 cross-border Myanmars: 66 health workers involved in community health or social services in remotely mountainous pocket villages in Myanmar but based in clinics at refugee camps in Tak-Mae Hong Son border provinces, northwest Thailand, and 21 nonhealth workers who developed malaria-like onset fever and visited clinics or local hospital in Tak and are local border people. All the samples were examined using ccirculating filarial antigen detection by commercially available Og4C3 ELISA specific for Wuchereria bancrofti and danti-HIV antibody-based ELISA specific for HIV type 1 and/or 2, as described in Bhumiratana et al. [26].
eUsing standard Giemsa-stained thick blood films (TBF), positive blood samples included infections with either single or mixed falciparum and vivax malaria.
f,gInfected male adults aged ≤35 years old, as no reporting of coinfection with malaria, LF, and HIV.